Gilead Sciences (GILD) Stock Week-Ahead Outlook: Pricing Deal Shockwave, HIV Pipeline Momentum, and Key Catalysts for Dec 22–26, 2025
December 21, 2025 — Gilead Sciences, Inc. (NASDAQ: GILD) heads into a holiday-shortened trading week with an unusually dense mix of policy headlines and pipeline momentum—two forces that can quickly reprice a large-cap biopharma stock even when overall market volume